Dear friend，

It's my great honor to talk with you！ I am Tomath Liu，BD manager of Shanghai Huilun Pharmaceutical Co.,Ltd. Shanghai Huilun is an innovative, research-based, commercial-stage pharmaceutical company based in China. 

 Here is our website, https://www.huilunbio.com/?l=en-us. 

 We notice that you have P-128 for treating Staphylococcus aureus infection. We are very interested in this area. We want diverse products for our patients, so I am talking to you to see if there is any chance to collaborate.It's probably a good chance for your product to licsence out to China.

How is it giong with P-128 phase Ⅱb study？And what‘s your future CDP？

Besides，our discovery team has researched some projects for infectious diseases, meanwhile we own successful marketing and clinical development experience in China. We believe our strength could help you make a great progress in China.


I would appreciate it if you could reply.